Skip to main content

Table 1 Hemodynamics and echocardiography data at 28 day after MCT injection

From: Role of P2X7R in the development and progression of pulmonary hypertension

Parameters

Sham

Vehicle

P/MCT + CA

P/MCT + DA

No. of surviving rats

15

18

16

15

Body weight, g

458 ± 8

390 ± 6*

436 ± 7*,†

428 ± 7*,†

Heart Rate, bpm

432 ± 9

446 ± 15

440 ± 10

437 ± 17

LV Cardiac Output (ml/min)

145 ± 3

105 ± 4*

107 ± 4*

116 ± 3.4*

RV Ejection Fraction (%)

68.3 ± 3.6

48.2 ± 4.4*

65.6 ± 4.2†

62.5 ± 5.1†

Pulmonary artery acceleration time, ms

34.2 ± 1

25.8 ± 1.4*

33 ± 0.9†

30.6 ± 0.7†

Pulmonary artery, cm

0.32 ± 0.01

0.43 ± 0.04*

0.34 ± 0.02†

0.35 ± 0.03†

Mean blood pressure

97.3 ± 4.2

90.5 ± 3.8

92.3 ± 2.2

89.4 ± 3.3

RV/BW (mg/g)

3.8 ± 0.2

12 ± 1*

6.2 ± 0.8*,†

7.1 ± 0.9*,†

RV wall thickness, cm

0.14 ± 0.02

0.23 ± 0.03*

0.16 ± 0.04†

0.18 ± 0.02†

RV area, mm2

12.6 ± 0.4

26 ± 0.8*

14.2 ± 0.5†

15.6 ± 0.4†

LV area, mm2

23.8 ± 0.4

24.6 ± 0.6

24.3 ± 0.7

25.8 ± 0.4

  1. All values are mean ± SD
  2. Abbreviations: RV right ventricle, LV left ventricle, BW body weight
  3. *p <0.05 compared with sham group
  4. † p < 0.05 compared with respective PAH vehicle group